OCTREOTIDE

octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

OCTREOTIDE (15629N)

octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
15629N
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19543)

Indication: Functional carcinoid tumour

Restriction (Streamlined authority code: 19544)

Indication: Vasoactive intestinal peptide secreting tumour (VIPoma)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $829.96 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Sandostatin LAR